title: O6-benzylguanine-resistant mutant MGMT genes improve hematopoietic cell tolerance to alkylating agents.
authors.affiliation: Division of Hematology/Oncology, Case Western Reserve University, Cleveland, Ohio, USA.
authors.forename: B M
authors.initials: BM
authors.lastname: Davis
authors.forename: O N
authors.initials: ON
authors.lastname: Koç
authors.forename: J S
authors.initials: JS
authors.lastname: Reese
authors.forename: S L
authors.initials: SL
authors.lastname: Gerson
mesh_terms: D000477:Alkylating Agents / Q000494:pharmacology*; D004351:Drug Resistance / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006147:Guanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000235:genetics*
chemical_list: D000477:Alkylating Agents; D004791:Enzyme Inhibitors; C064976:O(6)-benzylguanine; D006147:Guanine; D019853:O(6)-Methylguanine-DNA Methyltransferase